Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Here we provide a literature database for flavonoids, focused upon quercetin, rutin, isorhamnetin, and their related compounds. Original papers and reviews about in vitro, in vivo, and clinical pharmacologies are contained here.

Search

Result:: 1-10 Hits of 21

Nanoemulsions Based on Soluble Chenopodin/Alginate Complex for Colonic Delivery of Quercetin

Authors:: Arturo Intiquilla; Migdalia Arazo; Alexander Gamboa; Nelson Caro; Martin Gotteland; Alan Palomino-Calderón; Lilian Abugoch; Cristian Tapia

Reference:: Antioxidants; 2024; 13; 658

DOI:: 10.3390/antiox13060658

See Abstract

Dietary quercetin intake is associated with lower ulcerative colitis risk but not Crohn’s disease in a prospective cohort study and in vivo experiments

Authors:: Shi-Yuan Lu; Lintao Dan; Sishen Sun; Tian Fu; Jie Chen

Reference:: Food & Function; 2024; 15; 6553-6564

DOI:: 10.1039/D3FO05391A

See Abstract

Higher dietary quercetin intake is associated with lower risk of adverse outcomes among individuals with inflammatory bowel disease in a prospective cohort study

Authors:: Tianyu Wang; Shi-yuan Lu; Lintao Dan; Yuhao Sun; Tian Fu; Li Tian; Jie Chen

Reference:: The Journal of Nutrition; 2024; 154; 1861-1868

DOI:: 10.1016/j.tjnut.2024.04.025

See Abstract

Quercetin Attenuates Endoplasmic Reticulum Stress and Apoptosis in TNBS-Induced Colitis by Inhibiting the Glucose Regulatory Protein 78 Activation

Authors:: Yeter Topçu-Tarladaçalışır; Melike Sapmaz-Metin; Zeynep Mercan; Deniz Erçetin

Reference:: Balkan Medical Journal; 2024; 41; 30-37

DOI:: 10.4274/balkanmedj.galenos.2023.2023-10-9

See Abstract

Anti-inflammatory effects of the selective phosphodiesterase 3 inhibitor, cilostazol, and antioxidants, enzymatically-modified isoquercitrin and α-lipoic acid, reduce dextran sulphate sodium-induced colorectal mucosal injury in mice

Authors:: Yumi Kangawa; Toshinori Yoshida; Hajime Abe; Yoshiki Seto; Taishi Miyashita; Michi Nakamura; Tohru Kihara; Shim-mo Hayashi; Makoto Shibutani

Reference:: Experimental and Toxicologic Pathology; 2017; 69; 179-186

DOI:: 10.1016/j.etp.2016.12.004

See Abstract

Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review

Authors:: Elham Zarenezhad; Hussein T. Abdulabbas; Ahmed Shayaa Kareem; Seyed Amin Kouhpayeh; Silvia Barbaresi; Sohrab Najafipour; Abdulbaset Mazarzaei; Mitra Sotoudeh; Abdolmajid Ghasemian

Reference:: Archives of Microbiology; 2023; 205; 252

DOI:: 10.1007/s00203-023-03590-0

See Abstract

Oral pectin/oligochitosan microspheres for colon-specific controlled release of quercetin to treat inflammatory bowel disease

Authors:: Shisuo Jing; Huayuan Chen; Ergang Liu; Meng Zhang; Feng Zeng; Huan Shen; Yuefei Fang; Bahtiyor Muhitdinov; Yongzhuo Huang

Reference:: Carbohydrate Polymers; 2023; 316; 121025

DOI:: 10.1016/j.carbpol.2023.121025

See Abstract

The synergistic effect of epigallocatechin-3-gallate and quercetin coloaded hydrogel beads on inflammatory bowel disease

Authors:: Miao Hu; Yuyang Huang; Xiaoqian Du; Guannan Liu; Baokun Qi; Yang Li

Reference:: Food & Function; 2023; 14; 4539-4551

DOI:: 10.1039/D2FO04029H

See Abstract

Quercetin effectively improves LPS-induced intestinal inflammation, pyroptosis, and disruption of the barrier function through the TLR4/NF-κB/NLRP3 signaling pathway in vivo and in vitro

Authors:: Hui-Xin Zhang; Ye-Ye Li; Zhong-Jie Liu; Jiu-Feng Wang

Reference:: Food & Nutrition Research; 2022; 66; 8948

DOI:: 10.29219/fnr.v66.8948

See Abstract

Preclinical evidence for quercetin against inflammatory bowel disease: a meta-analysis and systematic review

Authors:: Shuangyuan Hu; Maoyaun Zhao; Wei Li; Pengfei Wei; Qingsong Liu; Shuanglan Chen; Jinhao Zeng; Xiao Ma; Jianyuan Tang

Reference:: Inflammopharmacology; 2022; 30; 2035–2050

DOI:: 10.1007/s10787-022-01079-8

See Abstract